CHESTERBROOK, PA — Persevere Therapeutics, Inc., a clinical-stage oncology biotechnology company, announced its launch following a period of stealth operations and the initial close of a seed ...

Chesterbrook's Persevere Therapeutics marked its emergence from stealth mode with a completed equity financing and product acquisition.

Re-establishing life after incarceration comes with continuous challenges, especially for Black communities, who face major economic difficulties beyond the prison walls. Alisa Malone, CEO of the ...

MEMPHIS, Tenn.--(BUSINESS WIRE)--Persevere, a 501(c)(3) non-profit organization with a mission to support at-risk and justice-impacted individuals, has been awarded $15.4 million in response to the ...

Opinions expressed by Entrepreneur contributors are their own. Every entrepreneur eventually faces an overriding challenge in developing a successful product: deciding when to pivot and when to ...